美国 · SEC FORM 4
Mirum Pharmaceuticals, Inc.
MIRM · Nasdaq · CIK 0001759425 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
46 同一窗口内观察到的 Form 4 交易行
31 sales · 15 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-01-23 · Heron Patrick J.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 6,985,385
- 上期报告
- 6,281,413
- 日均成交量
- 910,920
- 回补天数
- 7.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-23 | Heron Patrick J | 买入 (P) | Common Stock | 131,425 | USD 68.48 | USD 8,999,984 | SEC 申报 ↗ |
| 2025-03-17 | Heron Patrick J | 买入 (P) | Common Stock | 21 | USD 43.93 | USD 923 | SEC 申报 ↗ |
| 2025-03-14 | Heron Patrick J | 买入 (P) | Common Stock | 528 | USD 44.11 | USD 23,290 | SEC 申报 ↗ |
| 2025-03-11 | Heron Patrick J | 买入 (P) | Common Stock | 963 | USD 43.77 | USD 42,151 | SEC 申报 ↗ |
| 2025-03-10 | Heron Patrick J | 买入 (P) | Common Stock | 1,335 | USD 42.97 | USD 57,361 | SEC 申报 ↗ |
| 2025-03-07 | Heron Patrick J | 买入 (P) | Common Stock | 580 | USD 43.21 | USD 25,062 | SEC 申报 ↗ |
| 2025-03-06 | Heron Patrick J | 买入 (P) | Common Stock | 1,335 | USD 43.89 | USD 58,593 | SEC 申报 ↗ |
| 2025-03-05 | Heron Patrick J | 买入 (P) | Common Stock | 267 | USD 44.55 | USD 11,895 | SEC 申报 ↗ |
| 2025-03-04 | Heron Patrick J | 买入 (P) | Common Stock | 1,335 | USD 45.57 | USD 60,832 | SEC 申报 ↗ |
| 2024-09-18 | Heron Patrick J | 买入 (P) | Common Stock | 115 | USD 37.40 | USD 4,301 | SEC 申报 ↗ |
| 2024-09-06 | Heron Patrick J | 买入 (P) | Common Stock | 230 | USD 41.58 | USD 9,563 | SEC 申报 ↗ |
| 2024-03-27 | BJERKHOLT ERIC | 买入 (P) | Common Stock | 2,000 | USD 24.80 | USD 49,600 | SEC 申报 ↗ |
| 2024-03-18 | BJERKHOLT ERIC | 买入 (P) | Common Stock | 2,000 | USD 25.80 | USD 51,600 | SEC 申报 ↗ |
| 2023-11-09 | Heron Patrick J | 买入 (P) | Common Stock | 2,910 | USD 28.30 | USD 82,353 | SEC 申报 ↗ |
| 2023-09-13 | Heron Patrick J | 买入 (P) | Common Stock | 2,625 | USD 31.02 | USD 81,428 | SEC 申报 ↗ |
Form 4 申报证据
107 transaction lines in the latest 365-day window; 349 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Peetz Christopher | 期权行权／转换 (M) | Common Stock | 12,197 | USD 17.31 | USD 211,179 | SEC 申报 ↗ |
| 2026-09-14 | BJERKHOLT ERIC | 卖出 (S) | Common Stock | 9,943 | USD 98.37 | USD 978,093 | SEC 申报 ↗ |
| 2026-09-11 | BJERKHOLT ERIC | 期权行权／转换 (M) | Common Stock | 18,333 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Peetz Christopher | 期权行权／转换 (M) | Common Stock | 12,197 | USD 17.31 | USD 211,179 | SEC 申报 ↗ |
| 2026-09-14 | BJERKHOLT ERIC | 卖出 (S) | Common Stock | 9,943 | USD 98.37 | USD 978,093 | SEC 申报 ↗ |
| 2026-09-11 | BJERKHOLT ERIC | 期权行权／转换 (M) | Common Stock | 18,333 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-02 | Howe Jolanda | 卖出 (S) | Common Stock | 658 | USD 100.00 | USD 65,800 | SEC 申报 ↗ |
| 2026-09-01 | Peetz Christopher | 卖出 (S) | Common Stock | 30,000 | USD 98.68 | USD 2,960,401 | SEC 申报 ↗ |
| 2026-09-01 | Peetz Christopher | 期权行权／转换 (M) | Common Stock | 30,000 | USD 2.94 | USD 88,200 | SEC 申报 ↗ |
| 2026-08-18 | Howe Jolanda | 卖出 (S) | Common Stock | 40,000 | USD 100.00 | USD 4,000,000 | SEC 申报 ↗ |
| 2026-08-18 | Howe Jolanda | 期权行权／转换 (M) | Common Stock | 40,000 | USD 6.27 | USD 250,800 | SEC 申报 ↗ |
| 2026-08-11 | BJERKHOLT ERIC | 卖出 (S) | Common Stock | 6,001 | USD 99.90 | USD 599,500 | SEC 申报 ↗ |
| 2026-08-10 | Peetz Christopher | 卖出 (S) | Common Stock | 20,000 | USD 98.92 | USD 1,978,402 | SEC 申报 ↗ |
| 2026-08-10 | Peetz Christopher | 期权行权／转换 (M) | Common Stock | 20,000 | USD 2.94 | USD 58,800 | SEC 申报 ↗ |
| 2026-08-03 | Howe Jolanda | 卖出 (S) | Common Stock | 1,840 | USD 105.29 | USD 193,734 | SEC 申报 ↗ |
| 2026-07-06 | Peetz Christopher | 卖出 (S) | Common Stock | 20,000 | USD 122.27 | USD 2,445,382 | SEC 申报 ↗ |
| 2026-07-06 | Peetz Christopher | 期权行权／转换 (M) | Common Stock | 20,000 | USD 2.94 | USD 58,800 | SEC 申报 ↗ |
| 2026-07-06 | BJERKHOLT ERIC | 卖出 (S) | Common Stock | 5,000 | USD 122.25 | USD 611,273 | SEC 申报 ↗ |
| 2026-07-01 | Howe Jolanda | 卖出 (S) | Common Stock | 2,721 | USD 120.00 | USD 326,520 | SEC 申报 ↗ |
| 2026-06-17 | Howe Jolanda | 卖出 (S) | Common Stock | 2,594 | USD 101.95 | USD 264,458 | SEC 申报 ↗ |
| 2026-06-09 | BJERKHOLT ERIC | 期权行权／转换 (M) | Common Stock | 2,393 | USD 26.49 | USD 63,391 | SEC 申报 ↗ |
| 2026-06-08 | BJERKHOLT ERIC | 卖出 (S) | Common Stock | 5,000 | USD 93.82 | USD 469,077 | SEC 申报 ↗ |
| 2026-06-05 | Radovich Peter | 期权行权／转换 (M) | Common Stock | 16,988 | USD 19.19 | USD 326,000 | SEC 申报 ↗ |
| 2026-06-01 | Ramasastry Saira | 卖出 (S) | Common Stock | 3,977 | USD 100.00 | USD 397,700 | SEC 申报 ↗ |
| 2026-06-01 | Peetz Christopher | 卖出 (S) | Common Stock | 30,000 | USD 95.84 | USD 2,875,103 | SEC 申报 ↗ |
| 2026-06-01 | Peetz Christopher | 期权行权／转换 (M) | Common Stock | 30,000 | USD 2.94 | USD 88,200 | SEC 申报 ↗ |
| 2026-05-29 | Walbert Timothy P | 期权行权／转换 (M) | Common Stock | 3,977 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Ramasastry Saira | 期权行权／转换 (M) | Common Stock | 3,977 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Fischer Laurent | 期权行权／转换 (M) | Common Stock | 3,977 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-29 | Cardon Lon | 期权行权／转换 (M) | Common Stock | 3,977 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-15 | Ramasastry Saira | 卖出 (S) | Common Stock | 2,000 | USD 109.47 | USD 218,940 | SEC 申报 ↗ |
| 2026-05-15 | Ramasastry Saira | 期权行权／转换 (M) | Common Stock | 2,000 | USD 23.51 | USD 47,020 | SEC 申报 ↗ |
| 2026-04-15 | Ramasastry Saira | 卖出 (S) | Common Stock | 2,000 | USD 96.90 | USD 193,800 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MIRM |
| CIK | 0001759425 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 349 transaction lines from 2020-03-19 to 2026-10-06 31 P purchase lines · 142 S sale lines · 176 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.